OKT3 monoclonal antibody therapy and visual loss.
Horina
J H
JH
Horn
S
S
Holzer
H
H
Langmann
G
G
D003586:Cytomegalovirus Infections / Q000175:diagnosis / Q000209:etiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D016030:Kidney Transplantation / Q000009:adverse effects; D016853:Muromonab-CD3 / Q000009:adverse effects*; D014786:Vision Disorders / Q000209:etiology*
D007166:Immunosuppressive Agents; D016853:Muromonab-CD3